rAAVrh74.MCK.GALGT2
- Generic Name
- rAAVrh74.MCK.GALGT2
- Drug Type
- Biotech
Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Kevin Flanigan
- Target Recruit Count
- 2
- Registration Number
- NCT03333590
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath